Methylene Blue

Methylene Blue

Methylene blue is a century-old synthetic dye that's been quietly used in medicine since the late 1800s, originally for malaria and now FDA-approved for treating methemoglobinemia. The reason it shows up in modern longevity and cognitive circles is what it does inside your mitochondria: it slips into the electron transport chain and helps your cells make energy more efficiently, especially in the brain. People mainly take it for mental clarity, focus, and memory, with secondary interest in mitochondrial support as we age.
A small daily dose, blue or green urine for a day, and a subtle lift in mental sharpness that some people notice and others don't. It's one of the more interesting compounds in the cognitive enhancement category because it has actual human imaging data behind it, not just rodent studies.

Deep-dive

How it actually works
Most drugs work by binding a receptor. Methylene blue doesn't. It works as a redox cycler: it accepts electrons from NADH and donates them downstream in the electron transport chain, effectively bypassing damaged or sluggish complexes I and III to keep ATP production going. Gonzalez-Lima's group at UT Austin laid out this mechanism in detail, showing that low doses increase cytochrome c oxidase activity (the terminal enzyme of the chain) while higher doses inhibit it. This biphasic, hormetic curve is the single most important thing to understand about methylene blue. More is not better. More is worse.
The brain is unusually responsive to this because neurons are metabolically demanding and cytochrome oxidase activity in the brain isn't fixed, it scales with demand. Methylene blue is small, lipophilic, and crosses the blood-brain barrier easily, accumulating preferentially in metabolically active neurons in regions like the hippocampus and prefrontal cortex.
Human evidence
The strongest human data comes from a randomized double-blind fMRI trial by Rodriguez et al. in Radiology (2016). Twenty-six healthy adults aged 22 to 62 were given a single low oral dose (about 280 mg, or 4 mg/kg) or placebo and scanned during attention and memory tasks. Methylene blue increased fMRI activity in the insular cortex during sustained attention, increased activity in prefrontal, parietal, and occipital regions during a short-term memory task, and improved memory retrieval accuracy by 7%.
A separate randomized trial by Telch et al. in the American Journal of Psychiatry (2014) gave 260 mg of methylene blue to people with claustrophobia after exposure therapy sessions. It improved retention of fear extinction one month later, but only in participants who had a successful exposure session. People who had a poor session and got methylene blue actually did worse, which is a useful warning that it's a memory consolidator, it doesn't care what memory you're consolidating.
Limits of the evidence
Despite the cellular and animal evidence, large clinical trials in Alzheimer's using methylene blue or its derivative TRx0237 have largely failed to show clear benefit, partly due to dosing complications and the difficulty of blinding a drug that turns urine blue. There is no evidence that methylene blue prevents dementia in healthy people. The cognitive enhancement findings are from acute single-dose studies, not chronic use, so we don't have great data on what years of daily low-dose intake actually does.
There's also a quirky human imaging finding worth flagging: a 2023 study in the Journal of Cerebral Blood Flow & Metabolism found that acute methylene blue actually reduced cerebral blood flow and metabolic measures in both humans and rats, which the authors attributed to dosing potentially exceeding the hormetic window. The mechanism isn't as cleanly "more energy" as popular write-ups suggest.
Women specifically
Methylene blue research has historically been mixed-sex but rarely analyzed by sex. The Rodriguez fMRI trial included women, the Telch trial stratified randomization by gender, and pharmacokinetic studies have shown comparable absorption and clearance between men and women at the same mg/kg dose. There are no known sex-specific dose adjustments. Two practical notes for women: oestrogen modulates monoamine oxidase activity, and since methylene blue is itself a potent MAO-A inhibitor, the combined effect on mood and serotonergic tone may be slightly more variable across the menstrual cycle, though this hasn't been formally studied. Pregnancy is a hard no, methylene blue is contraindicated in pregnancy due to risk of neonatal hyperbilirubinemia and hemolytic anemia.
Older adults
The theoretical case for methylene blue is strongest in aging, since mitochondrial function declines with age and cytochrome oxidase activity drops in regions affected by cognitive decline. But the human evidence for slowing cognitive decline in older adults specifically is thin. The Alzheimer's trial failures should temper expectations. Older adults are also more likely to be on SSRIs, SNRIs, or other serotonergic medications, which makes the interaction risk meaningfully higher.
Other mechanisms worth knowing
Beyond mitochondrial electron shuttling, methylene blue inhibits monoamine oxidase A potently (Ki around 27 nM, in the range of prescription MAO inhibitors), inhibits nitric oxide synthase and guanylate cyclase, scavenges reactive oxygen species, and at high concentrations inhibits tau protein aggregation. The MAO-A inhibition is the source of the most serious drug interaction (covered below) and may also contribute directly to the mood and focus effects some users report.

Dosage:

  • Cognitive and general use: 0.5-2 mg/kg per day orally, which works out to roughly 35-140 mg for most adults. Most people who feel a benefit feel it at the lower end
  • Start low: begin at 0.5 mg/kg or 10-15 mg, whichever is lower, for at least a week before adjusting. Do not assume more is better, the dose-response curve is biphasic and higher doses inhibit the same enzyme low doses activate
  • Timing: take in the morning with food. The MAO-A inhibition can mildly disrupt sleep if taken late
  • How to take it: dilute drops in plenty of water in a glass (not plastic, it stains). Drinking through a straw helps avoid the blue tongue
  • Form and grade: pharmaceutical or USP grade only, with third-party certificate of analysis confirming purity above 99% and heavy metals below 10 ppm. Industrial and aquarium grade can contain arsenic, lead, cadmium, and mercury at meaningful levels. This isn't an area where you save money on the cheap version
  • Cycling: reasonable but not strictly necessary at low doses. Some people do 5 days on, 2 off
  • By body weight: men and women dose in the same range, no separate guideline. Older adults should start at the very low end given higher likelihood of medication interactions
  • Hard ceiling: stay well below 4 mg/kg. Above this threshold methylene blue shifts toward pro-oxidant effects and the risk of methemoglobinemia rises sharply
  • Skip entirely: pregnancy, breastfeeding, anyone on serotonergic medications (see below), anyone with G6PD deficiency

Here's what you can expect:

Most people don't feel a dramatic effect. The most commonly reported subjective changes are improved mental clarity, slightly better focus on demanding tasks, and a mild mood lift, often within an hour or two of dosing. Memory effects shown in the fMRI trial were modest: a 7% improvement in retrieval accuracy. Useful, but not transformative.
Your urine will turn blue or green within hours of dosing and stay that way for about 24 hours. This is harmless and just means the compound is being processed and excreted by your kidneys. Stool may also tint blue-green. Your tongue will turn blue if it touches the undiluted liquid, which is why you dilute it in water and ideally drink through a straw.
If you're going to feel anything noticeable, it usually shows up in the first week. If you've been at a sensible dose for a month and feel nothing, methylene blue probably isn't doing much for you. Stop rather than escalating.

Side effects & risks:

  • Serotonin syndrome. This is the non-negotiable risk. Methylene blue is a potent MAO-A inhibitor, demonstrated unequivocally in Ramsay et al., Br J Pharmacol (2007). Combining it with SSRIs, SNRIs, tricyclic antidepressants, MAOIs, tramadol, dextromethorphan, triptans, St John's Wort, or MDMA can trigger serotonin toxicity, which can be fatal. Doses as low as 0.75 mg/kg can reach serotonin-relevant CNS concentrations. If you are on any serotonergic medication, do not use methylene blue without a knowledgeable doctor
  • G6PD deficiency. People with G6PD deficiency can develop hemolysis from methylene blue. G6PD deficiency is most common in people of African, Mediterranean, Middle Eastern, and South Asian descent. If you don't know your status and you fall into one of these groups, get tested before starting
  • Methemoglobinemia at high doses. Paradoxically, the same drug that treats methemoglobinemia can cause it at higher doses (above roughly 4 mg/kg) by acting as an oxidant. Stay below this threshold
  • GI effects. Mild nausea, stomach discomfort, and occasionally loose stools, usually resolved by taking with food and diluting well
  • Headache, dizziness, sweating at the start of use, usually mild and self-limiting
  • Stained teeth and tongue if undiluted, reversible
  • Photosensitivity. Methylene blue is a photosensitizer and can increase skin sensitivity to bright light at higher doses
  • Pregnancy. Contraindicated, risk of neonatal hyperbilirubinemia and hemolytic anemia
  • Renal impairment. Use with caution, methylene blue is renally excreted
🩸

Blood markers

G6PD activity, baseline test if you're of African, Mediterranean, Middle Eastern, or South Asian ancestry, or if you don't know your family history. This is the single most important test to do before starting. If you're deficient, don't take it.
CBC (complete blood count), baseline to establish hemoglobin and red cell parameters. Recheck at 8-12 weeks of regular use to look for any signs of hemolysis (low hemoglobin, elevated reticulocytes, elevated LDH, low haptoglobin).
Liver enzymes (ALT, AST) and kidney function (creatinine, eGFR), baseline and at 8-12 weeks if using daily.
For people using occasionally at 0.5-1 mg/kg with no medications and no anaemia history, baseline CBC and a one-time G6PD check is enough. If you're using daily, dosing toward 2 mg/kg, on any medication, or have any history of anaemia or kidney issues, do the full panel and recheck. If you're on any serotonergic medication, the relevant test is your medication list, not your blood.
Methylene blue is FDA-approved for methemoglobinemia and otherwise sold outside the standard supplement framework. Quality varies hugely between sources.